nach oben

Quality of Life Research

Erschienen in:

01.06.2012

Symptom assessment in ambulatory oncology: initial validation of the nurse-developed Modified Ambulatory Care Flow Sheet (MACFS)

verfasst von: Susan Horsman, Karin Olson, Heather Au, Sunita Ghosh

Erschienen in: Quality of Life Research | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This paper reports relationships between symptoms assessed using a newly developed instrument for assessing patient-reported symptoms, the Modified Ambulatory Care Flow Sheet (MACFS), and other symptom assessment measures.

Methods

Using a cross-sectional design, patients on active treatment for colorectal cancer were recruited in an ambulatory setting of a tertiary care cancer center in western Canada. Participants completed the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire—Cancer 30, the Rotterdam Symptom Checklist Modified, Linear analog scales for pain and coping, and the MACFS, all at a single time point.

Results

We found moderate to strong correlations between the MACFS scores and scores on the other symptom measures used. The correlations were not as strong when using the MACFS symptom change scores, as when using the MACFS scores for the presence or absence of a particular symptom.

Conclusions

The MACFS reflects the symptom experience of colorectal cancer patients. Further evaluation in more diverse populations and of the relationship between MACFS symptom scores and quality of life will improve our understanding of the MACFS and of the cancer patient treatment experience.

Nur mit Berechtigung zugänglich

Doward, L. C., & McKenna, S. P. (2004). Defining patient-reported outcomes. Value in Health, 7(S), S4–S8.

Centers for Disease Control and Prevention. (2000). Measuring healthy days: Population assessment of health-related quality of life. Atlanta: Centers for Disease Control and Prevention.

de Kort, S. J., Willemse, P. H. B., Habraken, J. M., de Haes, H. C. J. M., Willems, D. L., & Richel, D. J. (2006). Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials. European Journal of Cancer, 42(7), 835–845.PubMedCrossRef

Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2004). Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. Journal of Clinical Oncology, 22(23), 4777–4784.CrossRef

Efficace, F., Bottomley, A., Vanvoorden, V., & Blazeby, J. M. (2004). Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. European Journal of Cancer, 40(2), 187–197.PubMedCrossRef

Armstrong, T. (2003). Symptoms experience: A concept analysis. Oncology Nursing Forum, 30(4), 601–606.PubMedCrossRef

Brown, V. (2001). The development and evaluation of an instrument to assess the adverse effects of cytotoxic chemotherapy. No. SPGS 608. Worthing, UK: NHS Executive South East Research Project Grant Scheme.

Dodd, M., Miaskowski, C., & Paul, S. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 465–470.PubMed

Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: The new frontier in symptom management research. Journal of The National Cancer Institute Monographs, 32, 17–21.

10.

Greenghalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measure in routine clinical practice: Lack of impact or lack of theory? Social Science and Medicine, 60(4), 833–843.CrossRef

11.

Bliven, D., Kaufman, S., & Spertus, J. (2001). Electronic collection of health-related quality of life data: Validity, time benefits and patient preference. Quality of Life Research, 10, 15–22.PubMedCrossRef

12.

Sloan, J. A., Aaronson, N., Cappelleri, J. C., Fairclough, D. L. D. H., Varricchio, C. D. S. N., & The Clinical Significance Consensus Meeting Group. (2002). Assessing the clinical significance of single items relative to summated scores. Report. Mayo Clinic Proceedings, 77(5), 479–487.PubMed

13.

Osoba, O., Aaronson, N., Zee, B., Sprangers, M., & Te Velde, A. (1997). Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. Quality of Life Research, 6(2), 103–108.PubMedCrossRef

14.

Velikova, G., & Wright, P. (2005). Individual patient monitoring. In P. Fayers & R. Hays (Eds.), Assessing quality of life in clinical trials (pp. 291–306). Oxford: Oxford University Press.

15.

Dell, R. B., Holleran, S., & Ramakrishnan, R. (2002). Sample size determination. ILAR Journal, 43(4), 207–213.PubMed

16.

Algina, J., & Olejnik, S. (2003). Sample size tables for correlation analysis with application in partial correlation and multiple regression analysis. Multivariate Behavioral Research, 38(3), 309–323.CrossRef

17.

Horsman, S., Olson, K., & Au, H. J. (2009). Symptom and quality of life assessment in ambulatory oncology: The evaluation of a clinical assessment tool. Paper presented at the meeting of the international society for quality of life research, New Orleans, LA.

18.

Horsman, S., & Au, H. J. (2009). The cancer patient in ambulatory oncology: Routine use of PROs into inform patient, nursing and physician interactions. In M. J. Santana & H. J. Au (Chair) Patient reported outcomes in clinical practice: Evolving science and accumulating experience. Symposium conducted at the meeting of the international society for quality of life research, New Orleans, LA.

19.

Horsman, S., & Au, H. J. (2008). A pilot project to assess clinical application of a PRO in ambulatory oncology. Montevideo: Poster session presented at the meeting of the International Society for Quality of Life Research.

20.

de Haes, J. C. J. M., & Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: Use of the Rotterdam symptom checklist in a multinational randomized trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. Annals of Oncology, 9(7), 745–750.PubMedCrossRef

21.

Stein, K. D., Denniston, M., Baker, F., Dent, M., Hann, D. M., Bushhouse, S., et al. (2003). Validation of a modified Rotterdam symptom checklist for use with cancer patients in the United States. Journal of Pain and Symptom Management, 26(5), 975–989.PubMedCrossRef

22.

Backer, J. H., Bakas, T., Bennett, S., & Pierce, P. K. (2000). Coping with stress. Programs of nursing research. In V. Hill Rice (Ed.), Handbook of stress, coping and health. Implications for nursing research theory and practice. Thousand Oaks, CA: Sage Publications.

23.

Aaronson, N., Ahmedzai, S., Bergman, B. et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of National Cancer Institute [serial online], 85, 365–375.

24.

Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality of life scores. Journal of Clinical Oncology, 16, 139–144.PubMed

25.

Salkind, N. J. (2006). Statistics for people who (think they) hate statistics. Thousand Oaks, CA: Sage Publications.

26.

SPSS for Windows Vista. (2007). Rel. 17.0.1. Chicago: SPSS Inc.

27.

Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2006). Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based study. European Journal of Cancer, 42(12), 1848–1857.PubMedCrossRef

28.

Gotay, C., & Wilson, M. (1998). Use of quality of life outcome assessments in current cancer clinical trials. Evaluation of Health Professions, 21, 157–178.CrossRef

29.

MacDonald, S., Linton, S., & Jansson-Fröjmark, M. (2008). Reconstructing the past on the original pain recall assessment form (OPRA). The Journal of Pain, 10(8), 809–817.CrossRef

30.

Hermansen-Kobulnicky, C., Wiederholt, J., & Chewning, B. (2004). Adverse effect monitoring: Opportunity for patient care and pharmacy practice. Journal of American Pharmaceutical Association, 44, 75–88.CrossRef

31.

Ballatori, E., & Roila, F. (2003). Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes, 1, 46.PubMedCrossRef

32.

Stull, D. E., Kline Leidy, N., Parasuraman, B., & Chassany, O. (2009). Optimal review periods for patient-reported outcomes: Challenges and potential solutions. Current Medical Research and Opinions, 25(4), 929–942.CrossRef

Titel: Symptom assessment in ambulatory oncology: initial validation of the nurse-developed Modified Ambulatory Care Flow Sheet (MACFS)
verfasst von: Susan Horsman
Karin Olson
Heather Au
Sunita Ghosh
Publikationsdatum: 01.06.2012
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 5/2012
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-011-9998-0

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

Erratum to: Bodyweight, gender, and quality of life: a population-based longitudinal study

Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies

Bodyweight, gender, and quality of life: a population-based longitudinal study

Selection of items for a computer-adaptive test to measure fatigue in patients with rheumatoid arthritis: a Delphi approach

ADHD burden of illness in older adults: a life course perspective